Concert Pharmaceuticals, Inc. (Nasdaq: CNCE) to Ring The Nasdaq Stock Market Closing Bell

ADVISORY, Oct. 24, 2016 (GLOBE NEWSWIRE) —

What:  
Concert Pharmaceuticals, Inc. (Nasdaq:CNCE), a clinical stage biopharmaceutical company focused on applying its DCE Platform® (deuterated chemical entity platform) to create novel medicines designed to address unmet patient needs, will visit the Nasdaq MarketSite in Times Square to mark the company’s 10th anniversary.

In honor of the occasion, Dr. Roger Tung, Co-Founder, President and CEO, will ring the Closing Bell. 

Where: 
Nasdaq MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio

When: 
Tuesday, October 25, 2016 – 3:45 p.m. to 4:00 p.m. ET 

Concert Pharmaceuticals Contact: 
Justine Koenigsberg
781-674-5284
ir@concertpharma.com

Nasdaq MarketSite: 
Emily Pan
(646) 441-5120 
emily.pan@nasdaq.com

Feed Information: 
Fiber Line (Encompass Waterfront): 4463

Gal 3C/06C 95.05 degrees West
18 mhz Lower
DL 3811 Vertical
FEC 3/4
SR 13.235
DR 18.295411
MOD 4:2:0
DVBS QPSK

Social Media: 
For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies, please visit our Facebook page: 
http://www.facebook.com/NASDAQ.

For photos from ceremonies and events, please visit our Instagram page: 
http://instagram.com/nasdaq

For livestream of ceremonies and events, please visit our YouTube page: 
http://www.youtube.com/nasdaq/live

For news tweets, please visit our Twitter page: 
http://twitter.com/nasdaq

For exciting viral content and ceremony photos, please visit our Tumblr page: 
http://nasdaq.tumblr.com/

Webcast:
A live stream of the Nasdaq Closing Bell will be available at:
https://new.livestream.com/nasdaq/live or http://www.nasdaq.com/about/marketsitetowervideo.asx

Photos:
To obtain a hi-resolution photograph of the Market Close, please go to http://business.nasdaq.com/discover/market-bell-ceremonies and click on the market close of your choice.

About Concert 
Concert Pharmaceuticals is a clinical stage biopharmaceutical company focused on applying its DCE Platform® (deuterated chemical entity platform) to create novel medicines designed to address unmet patient needs. The Company’s approach starts with approved drugs in which deuterium substitution has the potential to enhance clinical safety, tolerability or efficacy. Concert has a broad pipeline of innovative medicines targeting pulmonary diseases, including cystic fibrosis, central nervous systems (CNS) disorders, as well as autoimmune and inflammatory diseases. For more information please visit www.concertpharma.com.

About Nasdaq 
Nasdaq (Nasdaq:NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today’s global capital markets. As the creator of the world’s first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world’s securities transactions. Nasdaq is home to more than 3,700 listed companies with a market value of approximately $9.3 trillion and nearly 18,000 corporate clients. To learn more, visit: nasdaq.com/ambition or business.nasdaq.com.

-NDAQA-

 

Left Menu Icon
Right Menu Icon